Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC7 | O00311 | 1/20 | 0.36 |
| ▸ | DBF4 | Q9UBU7 | 1/20 | 0.36 |
| ▸ | ADORA3 | P0DMS8 | 4/20 | 0.34 |
| ▸ | ADORA2A | P29274 | 4/20 | 0.34 |
| ▸ | ADORA2B | P29275 | 4/20 | 0.34 |
| ▸ | ADORA1 | P30542 | 4/20 | 0.34 |
| ▸ | PDE2A | O00408 | 1/20 | 0.33 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.33 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.33 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23480329 | 0.80 | ADORA3 (0.32) | CDC7DBF4ADORA3ADORA2AADORA2B | |
| SCHEMBL10093833 | 0.74 | KDM4E (0.33) | CDC7DBF4 | |
| SCHEMBL19626331 | 0.71 | KDM4E (0.36) | — | |
| SCHEMBL16604726 | 0.71 | ADORA3 (0.34) | ADORA3ADORA2AADORA2BADORA1 | |
| SCHEMBL14699733 | 0.69 | HSD17B10 (0.41) | — | |
| SCHEMBL17339844 | 0.69 | ADORA3 (0.34) | ADORA3ADORA2AADORA2BADORA1 | |
| SCHEMBL19267555 | 0.67 | HSD17B10 (0.39) | — | |
| SCHEMBL77254 | 0.67 | HSD17B10 (0.39) | — | |
| SCHEMBL19626332 | 0.67 | KDM4E (0.36) | — | |
| SCHEMBL178967 | 0.67 | HSD17B10 (0.39) | ADORA3ADORA2AADORA2BADORA1PDE2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180099921-A1 | MIXTURE OF POLYMERIZABLE COMPOUND AND METHOD OF PRODUCING THE SAME | ZEON CORPORATION (JP) | 2018-04-12 | — | — | US | disclosed |
| US-20170335193-A1 | POLYMERIZABLE COMPOUND, MIXTURE, POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, POLYMER, OPTICAL FILM, OPTICALLY ANISOTROPIC PRODUCT, POLARIZING PLATE, FLAT PANEL DISPLAY DEVICE, ORGANIC ELECTROLUMINESCENCE DISPLAY DEVICE, AND ANTI-REFLECTION FILM | ZEON CORPORATION (JP) | 2017-11-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180099921-A1 | MIXTURE OF POLYMERIZABLE COMPOUND AND METHOD OF PRODUCING THE SAME | DDT, CA4, DNMT3B | CDC7 1233/4885DBF4 64/4885ADORA3 1142/4885 |
| US-20170335193-A1 | POLYMERIZABLE COMPOUND, MIXTURE, POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, POLYMER, OPTICAL FILM, OPTICALLY ANISOTROPIC PRODUCT, POLARIZING PLATE, FLAT PANEL DISPLAY DEVICE, ORGANIC ELECTROLUMINESCENCE DISPLAY DEVICE, AND ANTI-REFLECTION FILM | NR2E3, NR3C2, NR2C2 | CDC7 3162/4885DBF4 3392/4885ADORA3 627/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.